4049 |
Individualized Decision-making Between CABG and PCI for Multivessel or LM Disease: Expert Surgeon\'s View |
Mario Fl Gaudino |
Apr. 12. 21 |
4048 |
10-Year Final Report of PRECOMBAT Trial: Deep-Dive |
Duk-Woo Park |
Aug. 10. 20 |
4047 |
My Challenging LM PCI Case of the Year |
Duk-Woo Park |
Aug. 10. 20 |
4046 |
Imaging-guided PSP for Optimizing PCI |
Jung-Min Ahn |
Aug. 08. 20 |
4045 |
A Whole New World; HD IVUS [1] |
Yeon Soo Kang |
Aug. 08. 20 |
4044 |
Procedural Steps in TAVI [1] |
Seunghyun Lee |
Aug. 08. 20 |
4043 |
Physiologic Assessment of Coronary Artery Disease [1] |
Do Hyung Lim |
Aug. 08. 20 |
4042 |
Definition and Optimal Antithrombotic and PCI Strategies in HBR Patients: Updated Consensus of ARC-HBR Group |
Philip M. Urban |
Aug. 06. 20 |
4041 |
Choice of Stent Platforms in HBR Patients - Insights from the ONYX-ONE Trial |
Stephan Windecker |
Aug. 06. 20 |
4040 |
Atherectomy Expert\'s Choice: Rota vs. Orbital vs. Laser vs. Lithotripsy |
Antonio Colombo |
Aug. 06. 20 |